WL
WLACU
Willow Lane Acquisition Corp.
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
Apr 29, 2026
SEC
Willow Lane Acquisition Corp. announced it received no redemption requests ahead of its shareholder vote on the proposed
DEFA14A — Impact 4/10
Apr 29, 2026
SEC
Willow Lane Acquisition Corp. announced that no redemptions were requested for its public shares in connection with the
425 — Impact 8/10
Apr 29, 2026
SEC
Willow Lane Acquisition Corp. announced it received no redemption requests from public shareholders in connection with i
8-K — Impact 6/10
Analyst Ratings
2Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
DEFA14A
4/10
Willow Lane Acquisition Corp. announced it received no redemption requests ahead of its shareholder vote on the proposed
Apr 29, 2026
BULLISH
425
8/10
Willow Lane Acquisition Corp. announced that no redemptions were requested for its public shares in connection with the
Apr 29, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 6.0/10.
NEUTRAL
DEFA14A
4/10
Willow Lane Acquisition Corp. announced it received no redemption requests ahead of its shareholder
Apr 29, 2026
BULLISH
425
8/10
Willow Lane Acquisition Corp. announced that no redemptions were requested for its public shares in
Apr 29, 2026
BULLISH
8-K
6/10
Willow Lane Acquisition Corp. announced it received no redemption requests from public shareholders
Apr 29, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 88% buy across 8 analysts — 2 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.